If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Mar 2021 07:00

RNS Number : 8738T
Numis Corporation PLC
30 March 2021
 

Numis Corporation Plc ("Numis")

Trading Update

30 March 2021

Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the six month period ending 31 March 2021.

Numis is expected to report revenue in the region of £110m for the first half representing growth of more than 75% relative to the comparative period and comfortably ahead of the record performance in the second half of FY20.

Investment Banking revenues have benefited from favourable market conditions and are materially ahead of the first half of FY20 which was adversely impacted by the initial phase of the pandemic. The Investment Banking performance in the second half of FY20 was significantly stronger due to the volume of COVID-19 related fund raises, however revenues for the current six month period will exceed that performance, highlighting the strength of our Investment Banking platform. In particular, the positive equity market backdrop has supported an increase in IPO and M&A activity which has more than offset the tapering of fund raising activity for corporate clients. Our strong track record in equity capital markets and credibility in the digital economy has enabled us to capture a significant share of IPO transactions over this period which has contributed to strong growth in both average deal fees and deal volumes. 

Equities is also expected to deliver revenue ahead of both the comparative period and the second half of FY20. Institutional income has benefitted from growth in execution commissions attributable to market share gains and an increase in activity levels as indices recovered. Our trading book has also delivered particularly strong and consistent gains throughout the period. 

We have good momentum across the business, and we look forward to the second half with confidence. The Investment Banking pipeline is encouraging with further IPO and M&A activity anticipated. In addition, Numis has strong traction within private markets where our clients are some of the leading global technology disruptors. Engagement levels with the institutional clients of our Equities business are at record levels demonstrating the value they place on our partnership approach and guidance during these unprecedented times.

We remain focused on investing in the business to strengthen our capabilities in areas where we see further opportunities aligned to our growth strategy. We also recognise the importance of supporting our staff who continue to deliver excellent client service in circumstances which remain challenging. 

Numis will announce half year results for the six month period ending 31 March 2021 on 7 May 2021

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

Contacts:

Numis Corporation:

Alex Ham & Ross Mitchinson, Co-Chief Executives 020 7260 1245

Andrew Holloway, Chief Financial Officer 020 7260 1266

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Harrison Clarke 020 7184 4384

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and employs approximately 290 staff in London and New York.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKSBRAVUOUAR
Date   Source Headline
23rd Jan 20171:00 pmRNSDirectors' Dealing
19th Jan 20172:00 pmRNSDirectors' Dealing
18th Jan 201711:00 amRNSDirector's Dealing
12th Jan 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20179:51 amRNSAnnual Report and Annual General Meeting Notice
3rd Jan 201710:38 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20163:00 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 201611:05 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSPreliminary Results for the year ended 30 Sep 2016
1st Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20162:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20162:00 pmRNSDirector's Dealing
27th Oct 20161:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 201611:00 amRNSPurchase of shares in Close Period
3rd Oct 20167:00 amRNSTrading Update
14th Sep 20167:00 amRNSHolding(s) in Company
6th Sep 20169:45 amRNSDirector/PDMR Shareholding
5th Sep 20164:42 pmRNSGrant of Share Awards
22nd Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20163:11 pmRNSTransaction in Own Shares and Total Voting Rights
1st Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jul 201611:30 amRNSTransaction in Own Shares and Total Voting Rights
7th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20167:00 amRNSBoard Appointments
29th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
22nd Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 201611:47 amRNSDirector's Dealing
24th May 20163:16 pmRNSPosting of Interim Report
23rd May 20163:00 pmRNSHolding(s) in Company
19th May 20162:12 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 201610:00 amRNSTransfer of Shares from Treasury to EBT and TVR
13th May 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
9th May 20169:39 amRNSTransfer of Shares from Treasury to EBT and TVR
6th May 20167:01 amRNSBoard Changes
6th May 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.